XTANDI Adverse Event: Pancreatic carcinoma metastatic
XTANDI Adverse Event: Pancreatic carcinoma metastatic is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: XTANDI; Product category: Drug; Primary reaction: Pancreatic carcinoma metastatic.
| Primary drug | XTANDI |
|---|---|
| Product category | Drug |
| Primary reaction | Pancreatic carcinoma metastatic |
| All reactions | Pancreatic carcinoma metastatic |
| Seriousness | Serious |
| Patient outcome | Fatal |
| Patient sex | Male |
| All drugs reported | XTANDI |
| Reporter country | US |
| Reporter type | 5 |
| Report date | 20140313 |
| Report ID | 10006201 |
$299/mo
Try FDATracker →